Abstract Introduction: Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are novel agents with proven cardiovascular (CV) benefits
Retatrutide appears optimized for maximum weight loss, while Survodutide seems designed with metabolic health and liver function as primary considerations
Sustained-release niacin formulations, such as Niacin SR Tablets, differ significantly from immediate-release products in their drug delivery characteristics, side effect profiles, and dosing requirements
Legal Disclaimer: Wegovy 1mg Injection is a specialized pharmacological product
Keywords included terms related to glucagon-like peptide-1 receptor agonists (e.g., Glucagon-Like Peptide-1, GLP-1), mental health outcomes (e.g., Depression, Mental Disorder*, Psychiatric Disease*, Depressive Symptoms), and weight-related conditions (e.g., Obesity, Overweight, Weight Gain)
Zepbound, Semaglutide, and Wegovy offer substantial benefits for effective long-term weight management